Literature DB >> 34499322

RNA binding motif 47 (RBM47): emerging roles in vertebrate development, RNA editing and cancer.

Pavan Kumar Mysuru Shivalingappa1, Vaishali Sharma1, Anjali Shiras1, Sharmila A Bapat2.   

Abstract

RNA-binding proteins (RBPs) are critical players in the post-transcriptional regulation of gene expression and are associated with each event in RNA metabolism. The term 'RNA-binding motif' (RBM) is assigned to novel RBPs with one or more RNA recognition motif (RRM) domains that are mainly involved in the nuclear processing of RNAs. RBM47 is a novel RBP conserved in vertebrates with three RRM domains whose contributions to various aspects of cellular functions are as yet emerging. Loss of RBM47 function affects head morphogenesis in zebrafish embryos and leads to perinatal lethality in mouse embryos, thereby assigning it to be an essential gene in early development of vertebrates. Its function as an essential cofactor for APOBEC1 in C to U RNA editing of several targets through substitution for A1CF in the A1CF-APOBEC1 editosome, established a new paradigm in the field. Recent advances in the understanding of its involvement in cancer progression assigned RBM47 to be a tumor suppressor that acts by inhibiting EMT and Wnt/[Formula: see text]-catenin signaling through post-transcriptional regulation. RBM47 is also required to maintain immune homeostasis, which adds another facet to its regulatory role in cellular functions. Here, we review the emerging roles of RBM47 in various biological contexts and discuss the current gaps in our knowledge alongside future perspectives for the field.
© 2021. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  C to U RNA editing; Cancer; EMT; Embryonic development; RNA-binding motif 47 (RBM47); Wnt/β-catenin signaling

Mesh:

Substances:

Year:  2021        PMID: 34499322     DOI: 10.1007/s11010-021-04256-5

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  62 in total

Review 1.  A census of human RNA-binding proteins.

Authors:  Stefanie Gerstberger; Markus Hafner; Thomas Tuschl
Journal:  Nat Rev Genet       Date:  2014-11-04       Impact factor: 53.242

Review 2.  Principles and properties of eukaryotic mRNPs.

Authors:  Sarah F Mitchell; Roy Parker
Journal:  Mol Cell       Date:  2014-05-22       Impact factor: 17.970

Review 3.  A brave new world of RNA-binding proteins.

Authors:  Matthias W Hentze; Alfredo Castello; Thomas Schwarzl; Thomas Preiss
Journal:  Nat Rev Mol Cell Biol       Date:  2018-01-17       Impact factor: 94.444

Review 4.  Global Approaches in Studying RNA-Binding Protein Interaction Networks.

Authors:  Erin L Sternburg; Fedor V Karginov
Journal:  Trends Biochem Sci       Date:  2020-04-02       Impact factor: 13.807

5.  Rhou maintains the epithelial architecture and facilitates differentiation of the foregut endoderm.

Authors:  David A F Loebel; Joshua B Studdert; Melinda Power; Tania Radziewic; Vanessa Jones; Leigh Coultas; Yvette Jackson; Renuka S Rao; Kirsten Steiner; Nicolas Fossat; Lorraine Robb; Patrick P L Tam
Journal:  Development       Date:  2011-09-08       Impact factor: 6.868

6.  RNA binding motif (RBM) proteins: a novel family of apoptosis modulators?

Authors:  Leslie C Sutherland; Nina D Rintala-Maki; Ryan D White; Cory D Morin
Journal:  J Cell Biochem       Date:  2005-01-01       Impact factor: 4.429

7.  A Y chromosome gene family with RNA-binding protein homology: candidates for the azoospermia factor AZF controlling human spermatogenesis.

Authors:  K Ma; J D Inglis; A Sharkey; W A Bickmore; R E Hill; E J Prosser; R M Speed; E J Thomson; M Jobling; K Taylor
Journal:  Cell       Date:  1993-12-31       Impact factor: 41.582

8.  rbm47, a novel RNA binding protein, regulates zebrafish head development.

Authors:  Rui Guan; Suzan El-Rass; David Spillane; Simon Lam; Yuodong Wang; Jing Wu; Zhuchu Chen; Anan Wang; Zhengping Jia; Armand Keating; Jim Hu; Xiao-Yan Wen
Journal:  Dev Dyn       Date:  2013-09-30       Impact factor: 3.780

9.  A compendium of RNA-binding motifs for decoding gene regulation.

Authors:  Debashish Ray; Hilal Kazan; Kate B Cook; Matthew T Weirauch; Hamed S Najafabadi; Xiao Li; Serge Gueroussov; Mihai Albu; Hong Zheng; Ally Yang; Hong Na; Manuel Irimia; Leah H Matzat; Ryan K Dale; Sarah A Smith; Christopher A Yarosh; Seth M Kelly; Behnam Nabet; Desirea Mecenas; Weimin Li; Rakesh S Laishram; Mei Qiao; Howard D Lipshitz; Fabio Piano; Anita H Corbett; Russ P Carstens; Brendan J Frey; Richard A Anderson; Kristen W Lynch; Luiz O F Penalva; Elissa P Lei; Andrew G Fraser; Benjamin J Blencowe; Quaid D Morris; Timothy R Hughes
Journal:  Nature       Date:  2013-07-11       Impact factor: 49.962

10.  Genenames.org: the HGNC and VGNC resources in 2021.

Authors:  Susan Tweedie; Bryony Braschi; Kristian Gray; Tamsin E M Jones; Ruth L Seal; Bethan Yates; Elspeth A Bruford
Journal:  Nucleic Acids Res       Date:  2021-01-08       Impact factor: 16.971

View more
  4 in total

1.  RBM47 inhibits hepatocellular carcinoma progression by targeting UPF1 as a DNA/RNA regulator.

Authors:  Tao Guo; Ke You; Xi Chen; Yuqi Sun; Ying Wu; Ping Wu; Yingying Jiang
Journal:  Cell Death Discov       Date:  2022-07-14

Review 2.  RBM22, a Key Player of Pre-mRNA Splicing and Gene Expression Regulation, Is Altered in Cancer.

Authors:  Benoît Soubise; Yan Jiang; Nathalie Douet-Guilbert; Marie-Bérengère Troadec
Journal:  Cancers (Basel)       Date:  2022-01-27       Impact factor: 6.639

3.  RBM47 is a Critical Regulator of Mouse Embryonic Stem Cell Differentiation.

Authors:  Pavan Kumar Mysuru Shivalingappa; Divya Kumari Singh; Vaishali Sharma; Vivek Arora; Anjali Shiras; Sharmila A Bapat
Journal:  Stem Cell Rev Rep       Date:  2022-08-20       Impact factor: 6.692

Review 4.  The function and regulatory mechanism of RNA-binding proteins in breast cancer and their future clinical treatment prospects.

Authors:  Xingjia Lu; Jian Zhong; Linlin Liu; Wenzhu Zhang; Shengdi Zhao; Liang Chen; Yuxian Wei; Hong Zhang; Jingxuan Wu; Wenlin Chen; Fei Ge
Journal:  Front Oncol       Date:  2022-08-16       Impact factor: 5.738

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.